BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24096626)

  • 1. Mitochondrial cumulative damage induced by mitoxantrone: late onset cardiac energetic impairment.
    Rossato LG; Costa VM; Dallegrave E; Arbo M; Silva R; Ferreira R; Amado F; Dinis-Oliveira RJ; Duarte JA; de Lourdes Bastos M; Palmeira C; Remião F
    Cardiovasc Toxicol; 2014 Mar; 14(1):30-40. PubMed ID: 24096626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cumulative mitoxantrone-induced haematological and hepatic adverse effects in a subchronic in vivo study.
    Rossato LG; Costa VM; Dallegrave E; Arbo M; Dinis-Oliveira RJ; Santos-Silva A; Duarte JA; de Lourdes Bastos M; Palmeira C; Remião F
    Basic Clin Pharmacol Toxicol; 2014 Mar; 114(3):254-62. PubMed ID: 24119282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The age factor for mitoxantrone's cardiotoxicity: multiple doses render the adult mouse heart more susceptible to injury.
    Dores-Sousa JL; Duarte JA; Seabra V; Bastos Mde L; Carvalho F; Costa VM
    Toxicology; 2015 Mar; 329():106-19. PubMed ID: 25582955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naphthoquinoxaline metabolite of mitoxantrone is less cardiotoxic than the parent compound and it can be a more cardiosafe drug in anticancer therapy.
    Reis-Mendes A; Gomes AS; Carvalho RA; Carvalho F; Remião F; Pinto M; Bastos ML; Sousa E; Costa VM
    Arch Toxicol; 2017 Apr; 91(4):1871-1890. PubMed ID: 27629428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic concentrations of mitoxantrone elicit energetic imbalance in H9c2 cells as an earlier event.
    Rossato LG; Costa VM; Vilas-Boas V; de Lourdes Bastos M; Rolo A; Palmeira C; Remião F
    Cardiovasc Toxicol; 2013 Dec; 13(4):413-25. PubMed ID: 24046265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathways of cardiac toxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantrone.
    Damiani RM; Moura DJ; Viau CM; Caceres RA; Henriques JAP; Saffi J
    Arch Toxicol; 2016 Sep; 90(9):2063-2076. PubMed ID: 27342245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended regorafenib treatment can be linked with mitochondrial damage leading to cardiotoxicity.
    Boran T; Akyildiz AG; Jannuzzi AT; Alpertunga B
    Toxicol Lett; 2021 Jan; 336():39-49. PubMed ID: 33166663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolic profile of mitoxantrone and its relation with mitoxantrone-induced cardiotoxicity.
    Rossato LG; Costa VM; de Pinho PG; Arbo MD; de Freitas V; Vilain L; de Lourdes Bastos M; Palmeira C; Remião F
    Arch Toxicol; 2013 Oct; 87(10):1809-20. PubMed ID: 23545721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitoxantrone impairs proteasome activity and prompts early energetic and proteomic changes in HL-1 cardiomyocytes at clinically relevant concentrations.
    Costa VM; Capela JP; Sousa JR; Eleutério RP; Rodrigues PRS; Dores-Sousa JL; Carvalho RA; Lourdes Bastos M; Duarte JA; Remião F; Almeida MG; Varner KJ; Carvalho F
    Arch Toxicol; 2020 Dec; 94(12):4067-4084. PubMed ID: 32894303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omega-3 Fatty Acid Protects Against Arsenic Trioxide-Induced Cardiotoxicity In Vitro and In Vivo.
    Varghese MV; Abhilash M; Paul MV; Alex M; Nair RH
    Cardiovasc Toxicol; 2017 Apr; 17(2):109-119. PubMed ID: 26886836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chrysin attenuates cardiomyocyte apoptosis and loss of intermediate filaments in a mouse model of mitoxantrone cardiotoxicity.
    Anghel N; Cotoraci C; Ivan A; Suciu M; Herman H; Balta C; Nicolescu L; Olariu T; Galajda Z; Ardelean A; Hermenean A
    Histol Histopathol; 2015 Dec; 30(12):1465-75. PubMed ID: 26112963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective Effects of a Novel Agonist of Galanin Receptors Against Doxorubicin-Induced Cardiotoxicity in Rats.
    Studneva I; Palkeeva M; Veselova O; Molokoedov A; Ovchinnikov M; Sidorova M; Pisarenko O
    Cardiovasc Toxicol; 2019 Apr; 19(2):136-146. PubMed ID: 30238355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the aging effect of the anticancer drugs doxorubicin and mitoxantrone on cardiac mitochondrial proteome using a murine model.
    Brandão SR; Reis-Mendes A; Domingues P; Duarte JA; Bastos ML; Carvalho F; Ferreira R; Costa VM
    Toxicology; 2021 Jul; 459():152852. PubMed ID: 34246718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carnitine Supplementation Attenuates Sunitinib-Induced Inhibition of AMP-Activated Protein Kinase Downstream Signals in Cardiac Tissues.
    Sayed-Ahmed MM; Alrufaiq BI; Alrikabi A; Abdullah ML; Hafez MM; Al-Shabanah OA
    Cardiovasc Toxicol; 2019 Aug; 19(4):344-356. PubMed ID: 30644033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte colony-stimulating factor protects cardiac mitochondria in the early phase of cardiac injury.
    Hiraumi Y; Iwai-Kanai E; Baba S; Yui Y; Kamitsuji Y; Mizushima Y; Matsubara H; Watanabe M; Watanabe K; Toyokuni S; Matsubara H; Nakahata T; Adachi S
    Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H823-32. PubMed ID: 19136605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revisiting the Cardiotoxic Effect of Chloroquine.
    Blignaut M; Espach Y; van Vuuren M; Dhanabalan K; Huisamen B
    Cardiovasc Drugs Ther; 2019 Feb; 33(1):1-11. PubMed ID: 30635818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Cardiac Mitochondrial Molecular and Functional Responses to Acute Anthracycline Treatment in Wistar Rats.
    Pereira GC; Pereira SP; Pereira FB; Lourenço N; Lumini JA; Pereira CV; Bjork JA; Magalhães J; Ascensão A; Wieckowski MR; Moreno AJ; Wallace KB; Oliveira PJ
    Toxicol Sci; 2019 May; 169(1):137-150. PubMed ID: 30698778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Domoic acid impairment of cardiac energetics.
    Vranyac-Tramoundanas A; Harrison JC; Clarkson AN; Kapoor M; Winburn IC; Kerr DS; Sammut IA
    Toxicol Sci; 2008 Oct; 105(2):395-407. PubMed ID: 18596025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The C60-fullerene porphyrin adducts for prevention of the doxorubicin-induced acute cardiotoxicity in rat myocardial cells.
    Shetab Boushehri SV; Ostad SN; Sarkar S; Kuznetsov DA; Buchachenko AL; Orlova MA; Minaii B; Kebriaeezadeh A; Rezayat SM
    Acta Med Iran; 2010; 48(5):342-50. PubMed ID: 21287470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simvastatin induces mitochondrial dysfunction and increased atrogin-1 expression in H9c2 cardiomyocytes and mice in vivo.
    Bonifacio A; Mullen PJ; Mityko IS; Navegantes LC; Bouitbir J; Krähenbühl S
    Arch Toxicol; 2016 Jan; 90(1):203-15. PubMed ID: 25300705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.